Sheila Ridgway

I concluded the inquest into the death of Shella Winifred Ridgway on 29ih June 2018 She died from la Multi-organ failure Ib Sepsis secondary to hospital acquired pneumonia II Ischaemic colitis, Arterial disease to both lower limbs treated 13th and 14th December 2016, Thrombolysis to right femoral occlusion (secondary to stoppage of antiplatelet medication 21st December 2016) , Systemic hypertension, Anaemia

The deceased was referred by her GP to the Alexandra Hospital (BMI) on 8h November 2016 with suspected vascular disease to lower limbs Investigations revealed widespread arterial disease In both her She was admitted to Alexandra Hospital on 13th December 2016 and underwent angioplasty to the diseased blood vessels in both There were no post procedural complications and she was discharged home on 15th December 2016 Postoperatively she was commenced on dual antiplatelet therapy to reduce the risk of blockage to treated arteries The deceased was also under the Investigation for blackouts by a cardiologist at the Alexandra Hospital. As part of the investigations it was recommended that the deceased should have the Insertion of a loop ECG recorder To reduce the risk of associated bleeding with this procedure the deceased was advised by letter that she should discontinue her dual antiplatelet therapy 5 prior to admission for this procedure which was planned for on the 21st December 2016 However; there was no communication between the treating surgeon and the cardiologist as to the necessity for continuing with the dual antiplatelet therapy with regards to any ongoing risks of arterial occlusion in the The deceased was admitted to Wythenshawe Hospital on 20th December 2017 with a painful,_cold pulseless right leg Investigations revealed occlusion of the_previously City artery the legs the legs the days legs: treated right superficial femoral artery, and on 21st December she underwent successful thrombolysis treatment for this. Post thrombolysis treatment she was once again commenced on dual antiplatelet treatment; On 27th December 2017 she developed diarrhoea, for which Investigations and treatment were commenced She was reviewed by the gastroenterology team and a CT abdomen was requested which revealed non-specific Inflammatory change, most likely Infective In nature Advice was sought from the consultant microblologist regarding the appropriate antibiotics to treat this The administration of the antibiotic treatment appears to have been delayed due to a fallure to order the necessary antiblotic Evidence subsequently given by a different consultant microbiologist from within same hospital stated that bacterial culture results (which were only available after the deceased's death) showed that the organism cultured was not susceptible to the antibiotic Initially recommended The delay In administration of the recommended antibiotic was therefore unlikely to have been significant The deceased was also commenced on intravenous fluids, but evidence was heard of omissions and poor documentation In relation to this Despite ongoing treatment the deceased's condition deteriorated with evidence of deteriorating renal function, low blood pressure and worsening of inflammatory markers on blood tests The deceased was seen by the Intensive care and outreach teams on 9 December 2017 At this time she was found to have developed multi-organ fallure due to sepsis A CT abdomen and pelvis revealed left lung consolidation consistent with pneumonia and chronic Ischaemic colitis It was deemed that escalation of medical treatment would be futile and not in the best Interests of the deceased The deceased was referred to the palliative care team for her ongoing care The deceased died at 16.10hrs on 9 January 2017

In my opinion action should be taken to prevent future deaths and believe you and your organisation have the power to take such action